ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Sectoral-PharmaRank #27
5/5
NAV (2026-07-17)
₹43.32
AUM
₹6,624.58 Cr
Exp. Ratio: 2.09%
RISK LEVEL
Very High
Returns & Performance
1 Year6.41%4.22% vs cat avgRank #24
3 Year24.51%2.50% vs cat avgRank #2
5 Year15.50%2.38% vs cat avgRank #1
Since Launch20.07%--
Fund vs Category Average
1Y
6.41%-4.22%
3Y
24.51%+2.50%
5Y
15.50%+2.38%
Pros & Cons
Pros
✔Strong 3Y track record vs category
✔Above category avg 5Y returns
✔No lock-in period
Cons
✖1Y returns trail category average
✖Higher expense ratio (2.09%)
✖1Y category rank outside top 15 (#24)
✖Overall rank #27 in category
ISININF109KC1GE9
NAV₹43.32
NAV Date2026-07-17
AUM₹6,624.58 Cr
Expense Ratio2.09%
RiskVery High
Rating5 / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.1993-10-12
INVESTMENT OBJECTIVE
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Exit Load1.00%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.
Sharmila D'Silva
Ms. D'Silva is CA and BAF
She joined ICICI Prudential AMC Limited in September 2016.
